Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer.

摘要

The present invention relates to a new method of adjuvant therapy in the treatment of early breast cancer, comprising administering six cycles of docetaxel, doxorubicin and cyclophosphamide to a patient in need thereof, wherein said dosages have a marked therapeutic effect when compared to other adjuvant therapies.